Mutations in NPT2A or NHERF1 cause elevated renal phosphate excretion and hypophosphatemia in patients, thus highlighting an essential role of the NPT2A-NHERF1 axis in bone and kidney physiology. Here, NHERF1 is linked to hypophosphatemia.